[ORGANIZATION]
upadacitinib
Featured in 11 tracked stories · first seen
Situations
AbbVie IBD treatment clinical efficacy data
2 clusters · 5 sources · last updated
Latest: AbbVie reports clinical remission data for IBD treatments
AbbVie has presented new clinical data regarding the efficacy of its inflammatory bowel disease (IBD) treatments, specifically risankizumab (SKYRIZI) and upadacitinib (RINVOQ), for patients with Crohn’s disease and ulcer
Upadacitinib expanded approval for skin and arthritis
4 clusters · 22 sources · last updated
Latest: European Commission approves upadacitinib for three immune-mediated diseases
Clinical trials for the Janus kinase (JAK) inhibitor upadacitinib have demonstrated success in treating severe alopecia areata by blocking inflammatory signals via the JAK/STAT pathway. Research indicates that up to 23 p
Health studies on grip strength and mortality risk
2 clusters · 15 sources · last updated
Latest: Hypertension poses high risks for stroke and dementia
Research studies have examined the relationship between physical metrics, such as grip strength and body composition, and their impact on mortality and respiratory health. One study involving 5,674 American adults ident
Also covered in
-
Italy: Advocates seek recognition for alopecia and vitiligo
[HEALTH] · 24 sources ·